Technology News and Research

RSS

Stanley awards $15 million to provide operation, infrastructure support for Nationwide Health Information Network

Stanley, Inc., a leading provider of systems integration and professional services to the U.S. federal government, today announced that it was awarded two time-and-materials contracts valued at $15 million, with exercise of options, by the U.S. Department of Health and Human Services (DHHS), Office of the National Coordinator (ONC). These two awards follow an award from DHHS that the company announced on August 2, 2010, to provide operation and infrastructure support for the Nationwide Health Information Network. All three awards fall under the company's Chief Information Officer – Solutions and Partners 2 Innovations contract with the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).

13 Aug 2010

Sandata announces acquisition of Medical Management Technology Group's customer base

Sandata Technologies, LLC, a leading nationwide provider of information technology solutions to the home healthcare and social services communities today announced the acquisition of all of the home healthcare agency contracts of Medical Management Technology Group, Inc. in connection with the settlement of a patent infringement lawsuit.

13 Aug 2010

ARMC completes system-wide conversion to Masimo rainbow technology

Arrowhead Regional Medical Center (ARMC) in Colton, California, and Masimo, the inventor of Masimo rainbow Pulse CO-Oximetry, Masimo rainbow Acoustic Monitorin, and Masimo SET Measure-Through Motion and Low Perfusion pulse oximetry, today jointly announced the completion of ARMC's system-wide conversion to Masimo rainbow technology.

13 Aug 2010

PyroTITAN Humeral Resurfacing shoulder implant extends longevity of hemiarthroplasty joint replacement

Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, announces the implantation of an additional PyroTITAN Humeral Resurfacing Implant in Brisbane, Australia. The PyroTITAN was implanted last month at the Brisbane Private Hospital.

13 Aug 2010

Cancer Research Technology grants Valirx global rights to develop VAL 201 for cancer treatment

Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.

13 Aug 2010

Transdel second-quarter 2010 net loss decreases to $0.5 million

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced financial results for the three and six months ended June 30, 2010 and other activity during the second quarter.

13 Aug 2010

Transgenomic second-quarter net loss increases to $1.1 million

Transgenomic, Inc. today reported financial results for the three and six months ended June 30, 2010, and provided a business update.

13 Aug 2010

Arrowhead third-quarter 2010 net loss decreases to $0.4 million

Arrowhead Research Corporation today announced financial results for its fiscal 2010 third quarter ended June 30, 2010.

13 Aug 2010

FDA grants new 510(k) clearance for Fenwal's Amicus blood cell separator

Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator.

13 Aug 2010

Interbots to provide robot based therapy for autistic children

Interbots, Inc., a high-tech spin-off company associated with the Carnegie Mellon University Entertainment Technology Center has teamed up with the Autism Center of Pittsburgh to provide innovative robot-based therapy for children with autism.The program, "Character Therapy," through the use of the Interbot robot "Popchilla" will test the ability of children with autism with limited or no verbal skills.

13 Aug 2010

Antares Pharma second-quarter total revenue increases 78% to $3.1 million

Antares Pharma, Inc. today reported financial and operating results for the second quarter ended June 30, 2010.

13 Aug 2010

Nightingale to provide AIM Health Group with enterprise EMR and practice management solution

Nightingale Informatix Corporation, an application service provider of electronic medical record (EMR) software and related services today announces that it has signed a five-year agreement with the AIM Health Group to provide AIM's family practice, walk-in and pain management clinics with Nightingale On Demand, the Company's enterprise EMR and practice management solution.

12 Aug 2010

Gentium second-quarter total revenues increase to EUR 7.55 million

Gentium S.p.A. today reported financial results for the first half of 2010 and for the quarter ended June 30, 2010. The Company reports its financial condition and operating results using U.S. Generally Accepted Accounting Principles (GAAP). The Company's financial statements are prepared using the Euro as its functional currency.

12 Aug 2010

Amorfix first-quarter fiscal 2011 net loss from operations increases to $1,724,745

Amorfix Life Sciences, a product development company focused on misfolded protein diseases, today announced its operational and financial results for the three months ended June 30, 2010.

12 Aug 2010

FDA grants BioMimetic Therapeutics orphan drug designation for rhPDGF-BB in treatment of OCD

BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.

12 Aug 2010

Labopharm second-quarter total revenue increases to $6.8 million

Labopharm Inc. today reported its financial results for the second quarter and first six months ended June 30, 2010. All figures are in Canadian dollars unless otherwise stated.

12 Aug 2010

NextWave Pharmaceuticals, Tris Pharma sign agreement to enhance CNS product portfolio

NextWave Pharmaceuticals and Tris Pharma, both privately held companies, announced a new collaboration agreement to enhance NextWave's CNS product portfolio utilizing Tris Pharma's unique drug delivery technology for liquid and solid formulations. Tris has reacquired the rights to non CNS products including all the OTC products previously licensed to NextWave Pharmaceuticals.

12 Aug 2010

International cultivator wins Canada's prestigious medical marijuana quality award

An internationally-respected hydroponics medical marijuana cultivation educator won Canada's most prestigious medical marijuana quality award during a Toronto hydroponics expo competition...and he used a brand new type of hydroponics nutrients to do it.

12 Aug 2010

ALLOZYNE signs worldwide, co-exclusive licensing agreement with Sigma-Aldrich

ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.

12 Aug 2010

Pelleve Wrinkle Reduction System launched across U.S.

Pelleve, the revolutionary skin tightening system for nonablative skin rejuvenation, is now available through dermatologists, plastic surgeons, medspas and cosmetic surgery clinics across the country.

12 Aug 2010

Technology News and Research

Stanley awards $15 million to provide operation, infrastructure support for Nationwide Health Information Network

Sandata announces acquisition of Medical Management Technology Group's customer base

ARMC completes system-wide conversion to Masimo rainbow technology

PyroTITAN Humeral Resurfacing shoulder implant extends longevity of hemiarthroplasty joint replacement

Cancer Research Technology grants Valirx global rights to develop VAL 201 for cancer treatment

Transdel second-quarter 2010 net loss decreases to $0.5 million

Transgenomic second-quarter net loss increases to $1.1 million

Arrowhead third-quarter 2010 net loss decreases to $0.4 million

FDA grants new 510(k) clearance for Fenwal's Amicus blood cell separator

Interbots to provide robot based therapy for autistic children

Antares Pharma second-quarter total revenue increases 78% to $3.1 million

Nightingale to provide AIM Health Group with enterprise EMR and practice management solution

Gentium second-quarter total revenues increase to EUR 7.55 million

Amorfix first-quarter fiscal 2011 net loss from operations increases to $1,724,745

FDA grants BioMimetic Therapeutics orphan drug designation for rhPDGF-BB in treatment of OCD

Labopharm second-quarter total revenue increases to $6.8 million

NextWave Pharmaceuticals, Tris Pharma sign agreement to enhance CNS product portfolio

International cultivator wins Canada's prestigious medical marijuana quality award

ALLOZYNE signs worldwide, co-exclusive licensing agreement with Sigma-Aldrich

Pelleve Wrinkle Reduction System launched across U.S.

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News